Real-World Survival Outcomes and Prognostic Factors Among Patients Receiving First Targeted Therapy for Advanced Renal Cell Carcinoma: A SEER-Medicare Database Analysis.

@article{Pal2017RealWorldSO,
  title={Real-World Survival Outcomes and Prognostic Factors Among Patients Receiving First Targeted Therapy for Advanced Renal Cell Carcinoma: A SEER-Medicare Database Analysis.},
  author={Sumanta K Pal and Sameer R Ghate and Nanxin Li and Elyse Swallow and Miranda Peeples and Miriam L Zichlin and Jose Ricardo Perez and Neeraj Agarwal and Nicholas John Vogelzang},
  journal={Clinical genitourinary cancer},
  year={2017},
  volume={15 4},
  pages={e573-e582}
}
BACKGROUND The real-world survival outcomes and prognostic factors among patients receiving first-line targeted therapy for advanced renal cell carcinoma (aRCC) are not well known. PATIENTS AND METHODS Adult patients diagnosed with RCC and treated with first-line targeted therapy were identified from the Surveillance, Epidemiology, and End Results-Medicare database (January 1, 1993 to December 31, 2012). The patients were grouped into early (2006-2009) or late (2010-2012) targeted therapy era… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 3 times over the past 90 days. VIEW TWEETS
4 Citations
48 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 48 references

Epidemiology, pathology, a nd pathogenesis of renal cell carcinoma

  • MB Atkins, TK Choueiri
  • UpToDate. 2016. Accessed on: June
  • 2016

Prognostic factors in patients with r enal cell carcinoma

  • TK Choueiri
  • UpToDate
  • 2015

Similar Papers

Loading similar papers…